Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What strategies can be implemented to increase inpefa's market share?Cosentyx help with cost?Ferrous sulfate with milk?Clozapine monitoring blood tests?How much water should you drink when taking farxiga?
See the DrugPatentWatch profile for aristada
Aristada (aripiprazole lauroxil) is a long-acting injectable antipsychotic for schizophrenia maintenance, given every 4 to 8 weeks. Aristada Initio is its one-time "initiator" version, used only as a single 675 mg dose on day 1 to rapidly establish therapeutic drug levels.[1]
Aristada Initio kickstarts treatment because standalone Aristada takes weeks to reach steady-state aripiprazole levels. Patients get Initio plus an oral aripiprazole dose on day 1, then start Aristada (441 mg, 882 mg, or 1320 mg) on day 8 or later—no oral meds needed after that.[1][2] Aristada alone requires 21 days of oral aripiprazole buildup first.
Initio converts faster to active aripiprazole via an extra metabolic step, bridging the gap until Aristada builds up. This reduces relapse risk during early treatment.[2]
Both carry similar risks—akathisia, weight gain, injection-site pain, sedation. Initio's single use limits cumulative exposure. Neither is for acute agitation.[1][3] Sources [1]: Aristada Initio Prescribing Information (Alkermes) [2]: FDA Approval Summary [3]: Drugs.com Comparison
Other Questions About Aristada :